Literature DB >> 33395695

Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership.

Rebecca C Tatum1,2, Cathy M McGowan1, Rachel S Dean3, Joanne L Ireland1.   

Abstract

Pituitary pars intermedia dysfunction (PPID) is the most prevalent endocrine disorder of older equids. To date, key research areas likely to have the greatest impact on equine health have not been identified. In human medicine, public and patient involvement is widely used to inform research agendas. This study aimed to engage with veterinary surgeons and horse owners to identify evidence gaps ('uncertainties') and prioritise these into a list of the 10 most important PPID research questions. The James Lind Alliance (JLA) Priority Setting Partnership (PSP) Framework was adapted. Questions about the diagnosis, treatment and prognosis of PPID were gathered via an online survey targeting veterinary surgeons and horse owners with experience of PPID. Thematic analysis was used to form a longlist of collated indicative research questions (CIRQs), defined by the JLA as true 'evidence uncertainties' when not answered by a published, clinically relevant, up-to-date systematic review. In an interim prioritisation survey, questions were ranked by weighted scores creating a shortlist of 25 that were taken forward to the PSP workshop, where participants reached a consensus on the top 10. Useable responses containing ≥1 question were received from 524 respondents (92.6% owners, n = 485; 7.4% veterinary surgeons, n = 39). After screening for relevance, 1,260 individual questions were included in thematic analysis, resulting in 47 CIRQs. Interim prioritisation votes for the CIRQs were received from 360 respondents. The top 10 questions prioritised at the PSP workshop focused on long-term prognosis, diagnostic accuracy, efficacy of pergolide treatment, alternative treatment/management strategies and potential treatment options for poor responders to pergolide. The quantity of questions generated indicates an extensive number of uncertainties regarding the diagnosis, treatment and prognosis of PPID. The top 10 research questions will help to inform key areas for evidence synthesis and knowledge translation, and to direct future research into areas most important to end users involved in caring for and treating animals with PPID.

Entities:  

Mesh:

Year:  2021        PMID: 33395695      PMCID: PMC7781667          DOI: 10.1371/journal.pone.0244784

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  42 in total

Review 1.  Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors.

Authors:  J L Ireland; C M McGowan
Journal:  Vet J       Date:  2018-03-08       Impact factor: 2.688

2.  Searching the veterinary literature: a comparison of the coverage of veterinary journals by nine bibliographic databases.

Authors:  Douglas J C Grindlay; Marnie L Brennan; Rachel S Dean
Journal:  J Vet Med Educ       Date:  2012       Impact factor: 1.027

3.  Case series of equine pituitary pars intermedia dysfunction in a tropical climate.

Authors:  C W Spelta; J E Axon
Journal:  Aust Vet J       Date:  2012-10-11       Impact factor: 1.281

4.  What do I want from health research and researchers when I am a patient?

Authors:  I Chalmers
Journal:  BMJ       Date:  1995-05-20

5.  Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide.

Authors:  G A Perkins; S Lamb; H N Erb; B Schanbacher; D V Nydam; T J Divers
Journal:  Equine Vet J       Date:  2002-11       Impact factor: 2.888

Review 6.  Pituitary pars intermedia dysfunction: equine Cushing's disease.

Authors:  Harold C Schott
Journal:  Vet Clin North Am Equine Pract       Date:  2002-08       Impact factor: 1.792

Review 7.  Equine pituitary pars intermedia dysfunction.

Authors:  Dianne McFarlane
Journal:  Vet Clin North Am Equine Pract       Date:  2011-04       Impact factor: 1.792

8.  Pergolide treatment for Cushing's syndrome in a horse.

Authors:  M C Muñoz; F Doreste; O Ferrer; J González; J A Montoya
Journal:  Vet Rec       Date:  1996-07-13       Impact factor: 2.695

9.  Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.

Authors:  M A Miller; I D Pardo; L P Jackson; G E Moore; J E Sojka
Journal:  Vet Pathol       Date:  2008-01       Impact factor: 2.221

10.  Circulating beta-endorphin, adrenocorticotrophic hormone and cortisol levels of stallions before and after short road transport: stress effect of different distances.

Authors:  Esterina Fazio; Pietro Medica; Vincenzo Aronica; Loredana Grasso; Adriana Ferlazzo
Journal:  Acta Vet Scand       Date:  2008-03-03       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.